-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Magnetic resonance imaging (MRE) of the bowel plays an important role in evaluating intestinal inflammatory lesions in patients with Crohn's disease (CD)
Magnetic resonance imaging (MRE) of the bowel plays an important role in evaluating intestinal inflammatory lesions in patients with Crohn's disease (CD)
At this stage , the management of CD is moving towards objective measures of inflammation as well as symptoms .
Among the various grading systems for measuring CD efficacy by MRE, the best characterized is the Magnetic Resonance Activity Index (MaRIA)
The post hoc analysis of this prospective study included CD patients with endoscopic ulceration in ≥1 bowel segment who started biologic therapy
A total of 46 patients (median age, 36 years [IQR: 28-47]) were included
Figure 46-year-old woman with severe active Crohn's disease in the terminal ileum .
Figure 46-year-old woman with severe active Crohn's disease in the terminal ileum .
This study demonstrates that sMaRIA accurately describes treatment response to CD according to clinical criteria, with or without contrast -enhanced scanning .
Original source :
Agnès Fernàndez-Clotet , Víctor Sapena , Nunzia Capozzi , et al .
Agnès Fernàndez-Clotet Víctor Sapena Nunzia Capozzi ,et al Avoiding contrast-enhanced sequences does not compromise the precision of the simplified MaRIA for the assessment of non-penetrating Crohn's disease activity 10.
1007/s00330-021-08392-w 10.
1007/s00330-021- 08392-w
leave a message here